Albani
Andrea Albani, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20140059665 | FRAUD-PROOF LOCATION IDENTIFICATION SYSTEM - Systems and methods for facilitating check-ins that are resistant to common fraud scenarios while also being relatively inexpensive. One or more embodiments include displaying unique tokens in quick succession on a display positioned at the check-in location (e.g., a store, restaurant, or other business or location). Customers have a short period of time (e.g., a few seconds, five minutes, etc.) to scan a particular check-in token before a new token is displayed on the display. Each token may encode a pre-determined number or identification code that cannot be guessed by the user and that can be verified by the system to validate the check-in. By periodically changing the check-in token displayed to users and limiting each token to a single use within a short timeframe, users are prevented from checking in remotely. | 02-27-2014 |
Davide Albani, Merate (lc) IT
Patent application number | Description | Published |
---|---|---|
20090171110 | PROCESS FOR PREPARING N-METHYL-3, 4-DIMETHOXYPHENYLETHYLAMINE - Provided are intermediates useful for the preparation of verapamil and methods for their preparation. | 07-02-2009 |
Luigi Albani, Merate IT
Patent application number | Description | Published |
---|---|---|
20100295766 | WHITE BACKLIGHT FOR A DISPLAY - A display backlight is described which produces white light of a specified color point and from light sources of different chromaticities and in which the red wavelengths emitted by the light sources are emitted by light sources of two or more chromaticities from the group of at least three different chromaticities and arranged to be driven with the result that visible, red-colored artifacts are reduced at boundaries of high image contrast when the backlight is coupled to further display components and used for display of a grey scale image. The invention allows production of a display with an adjustable white color point but which also does not suffer from distracting red, fringe-like artefacts reported by users of displays comprising white backlights produced from red, green and blue light sources. A display incorporating the backlight is also described. | 11-25-2010 |
Massimiliano Albani, Volvera IT
Patent application number | Description | Published |
---|---|---|
20120328414 | Gas Turbine For Aeronautic Engines - In a turbine for aeronautic engines, a first and at least a second turbine disk rotating around a common axis respectively carrying a first and a second moving-blade crown, with which first and, respectively, second axial passages are defined through which a cooling air mass for the turbine disks can pass, a device for conveying cooling air being interposed between the first and the second axial passages to receive the mass of air passing through the first axial passages and send it through the second axial passages. | 12-27-2012 |
Mike Albani, Leverkusen DE
Patent application number | Description | Published |
---|---|---|
20140043047 | OCCUPANT DETECTION SYSTEM AND METHOD - An occupant detection system and method that uses an isolation assembly to isolate electrically a power supply providing power to a heater element for heating a vehicle seat from a sensing circuit that uses the heater element as an electrode for electric field or capacitance type occupant detection. The isolation assembly includes a common mode choke that by itself provides sufficient isolation when the sensing circuit excitation signal frequency is high enough, and provides switches that infrequently interrupt electrical power to the heater element so a humidity level can be determined using a relatively low excitation signal frequency. Knowing the humidity level is desirable to adjust a threshold use to determine if the sensing circuit indicates that the seat is empty, or is occupied. | 02-13-2014 |
Roberto Albani, Rome IT
Patent application number | Description | Published |
---|---|---|
20150027449 | Device of Contrast of Gastroesophageal Reflux in Children - The present invention concerns a device ( | 01-29-2015 |
Salvatore Albani, La Jolla, CA US
Patent application number | Description | Published |
---|---|---|
20120088678 | METHOD FOR PREDICTION OF RESPONSE TO RHEUMATOID ARTHRITIS THERAPEUTICS - The present invention is based in part on the identification of a signature marker profile of immune variables to diagnose an immune mediated disease or for prediction of response to an immune mediated disease therapeutic agent. Additionally, the present invention provides methods for the prediction of response to an immune mediated disease therapeutic agent. | 04-12-2012 |
Salvatore Albani, Encinitas, CA US
Patent application number | Description | Published |
---|---|---|
20100021485 | COMBINATION THERAPY METHOD AND FORMULATION - This invention concerns a pharmaceutical formulation and method for treating autoimmune disorders. The formulation and method provide for a combination therapy regimen wherein two separate substances are administered to a patient having or predisposed to having the disorder. The two components comprise at least one immunomodulatory peptide and a chloroquine derivative. The combination of the two components can be administered together or separately. | 01-28-2010 |
20100111992 | CYTOMEGALOVIRUS PEPTIDES AND METHODS OF USE THEREOF - A method of modulating an immune response in a subject is disclosed. The invention is based on the discovery that an effective therapeutic strategy for ameliorating the symptoms of cytomegalovirus infection can be achieved by administering an effective amount of a CMV-derived peptide. | 05-06-2010 |
20130225427 | METHOD FOR PREDICTION OF RESPONSE TO IMMUNE MEDIATED DISEASE THERAPEUTICS - The present invention is based in part on the identification of a signature marker profile of immune variables to diagnose an immune mediated disease or for prediction of response to an immune mediated disease therapeutic agent. Additionally, the present invention provides methods for the prediction of response to an immune mediated disease therapeutic agent. | 08-29-2013 |